Adverum Biotechnologies, Inc. ADVM
ADVM
Adverum Biotechnologies, Inc. ARTV
Artiva Biotherapeutics, Inc. GUTS
Fractyl Health, Inc. Common Stock STRO
Sutro Biopharma, Inc. DTIL
Precision BioSciences, Inc. MGX
Metagenomi, Inc. Common Stock ALXO
ALX Oncology Holdings Inc. ATYR
aTyr Pharma, Inc. BMEA
Biomea Fusion, Inc. PLRX
Pliant Therapeutics, Inc.
Adverum Biotechnologies, Inc. ARTV
Artiva Biotherapeutics, Inc. GUTS
Fractyl Health, Inc. Common Stock STRO
Sutro Biopharma, Inc. DTIL
Precision BioSciences, Inc. MGX
Metagenomi, Inc. Common Stock ALXO
ALX Oncology Holdings Inc. ATYR
aTyr Pharma, Inc. BMEA
Biomea Fusion, Inc. PLRX
Pliant Therapeutics, Inc.
Performance
| Periode | ADVM | ARTV | GUTS | STRO | DTIL | MGX | ALXO | ATYR | BMEA | PLRX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 77.24 % | 66.67 % | 8.98 % | 22.53 % | 2.24 % | 15.73 % | 188.84 % | -85.19 % | -40.25 % | -10.87 % |
| YTD | -9.17 % | -66.90 % | 5.40 % | -49.27 % | 6.82 % | -56.33 % | -5.13 % | -80.30 % | -61.79 % | -90.74 % |
| 1Y | -18.81 % | -68.93 % | 10.05 % | -53.82 % | -7.90 % | -48.92 % | 2.07 % | -74.83 % | -75.00 % | -90.75 % |
| 3Y | -34.93 % | -72.50 % | -82.53 % | -87.14 % | -86.08 % | -83.95 % | -87.09 % | -55.48 % | -80.44 % | -93.55 % |
| 5Y | -96.89 % | -72.50 % | -82.53 % | -95.49 % | -97.92 % | -83.95 % | -98.15 % | -55.48 % | -91.71 % | -95.51 % |
| 10Y | -94.78 % | -72.50 % | -82.53 % | -93.56 % | -99.04 % | -83.95 % | -95.07 % | -55.48 % | -91.71 % | -94.23 % |
| Depuis le début | -98.44 % | -72.50 % | -82.53 % | -93.56 % | -99.04 % | -83.95 % | -95.07 % | -55.48 % | -91.71 % | -94.23 % |